Zobrazeno 1 - 10
of 129
pro vyhledávání: '"BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Oncology"'
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Publikováno v:
Leukemia & Lymphoma
Volume 64
Issue 4
Volume 64
Issue 4
Splenomegaly s a hallmark ol primary (PMF) and secondary myelofibrosis {;SMF};, developing mostly due to extramedullary hematopoiesis. It represents tumour burden and correlates with unfavourable disease features. PMF and SMF may have distinct molecu
Autor:
Čović, Natko
CILJ ISTRAŽIVANJA: Mutacije BRCA1 i BRCA2 gena su poznati čimbenici rizika za nastanak raka dojke i jajnika. Spektar BRCA1/2 mutacija u bolesnica sa seroznim karcinomom jajnika visokog gradusa u Hrvatskoj još nije opisan. Ovakve izvješća su važ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c08ddbc7990fcbb6370f7b47917d0e17
https://repozitorij.svkst.unist.hr/islandora/object/mefst:2042
https://repozitorij.svkst.unist.hr/islandora/object/mefst:2042
Autor:
Vrdoljak, Josip
Uvod: Određivanje statusa pazušnih limfnih čvorova iznimno je važno za prognozu bolesti i pravilan odabir liječenja kod bolesnika oboljelih od raka dojke. Kod bolesnika određenih za neoadjuvantno sustavno liječenje (NST) klinički pregled i ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0135ac891d5a55269ea957f6b3b35e0c
https://urn.nsk.hr/urn:nbn:hr:171:497333
https://urn.nsk.hr/urn:nbn:hr:171:497333
Autor:
Ban, Marija
Dodatak trastuzumaba kemoterapiji predstavlja temelj adjuvantnog liječenja HER 2 pozitivnog raka dojke. Kliničke studije i meta-analize dodatka trastuzumaba pokazale su značajnu redukciju rizika povrata bolesti i smrti. Ipak, stvarnu vrijednost bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bb97f32904dfaef1b55ac2ecb511d763
https://urn.nsk.hr/urn:nbn:hr:171:534595
https://urn.nsk.hr/urn:nbn:hr:171:534595
Autor:
Bošković, Lidija
Cilj ovog istraživanja je bio utvrditi suradljivost postmenopauzalnih bolesnica s ranim invazivnim hormonski osjetljivim rakom dojke na adjuvantnu terapiju s nesteroidnim aromataznim inhibitorima, vitaminom D i kalcijem (ako je to propisano od onkol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::893a914734ab00d5c4e17ea7fb98c87d
https://urn.nsk.hr/urn:nbn:hr:171:209586
https://urn.nsk.hr/urn:nbn:hr:171:209586
Autor:
Bellesi, Gaia, Roganović, Jelena
Publikováno v:
Medicina Fluminensis : Medicina Fluminensis
Volume 59
Issue 2
Medicina Fluminensis
Volume 59
Issue 2
Medicina Fluminensis
Cilj: Prikazati slučaj pedijatrijske pacijentice sa sindromom gornjeg medijastinuma (SGM) kod koje je citološkom analizom pleuralnog i perikardijalnog izljeva postavljena preliminarna dijagnoza T-staničnog ne-Hodgkinovog limfoma (T-NHL) i zbog ži
Autor:
Čerina, Dora
Due to the scientifical and technological evolution, development of precise diagnostic-therapeutic tools, such as comprehensive genomic profiling, as well as targeted therapy, approach to patient is dramatically changing and medicine is turning towar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::807a284b808e31049b72656ca39de8f8
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1708
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1708
Autor:
Maria Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jaksic, Barbora Weinbergerová, Caroline Besson, Rafael F. Duarte, Federico Itri, Toni Valković, Tomáš Szotkovski, Alessandro Busca, Anna Guidetti, Andreas Glenthøj, Graham P. Collins, Valentina Bonuomo, Uluhan Sili, Guldane Cengiz Seval, Marina Machado, Raul Cordoba, Ola Blennow, Ghaith Abu-Zeinah, Sylvain Lamure, Austin Kulasekararaj, Iker Falces-Romero, Chiara Cattaneo, Jaap Van Doesum, Klára Piukovics, Ali S. Omrani, Gabriele Magliano, Marie-Pierre Ledoux, Cristina de Ramon, Alba Cabirta, Luisa Verga, Alberto López-García, Maria Gomes Da Silva, Zlate Stojanoski, Stef Meers, Tobias Lahmer, Sonia Martín-Pérez, Julio Dávila-Vals, Jens Van Praet, Michail Samarkos, Yavuz M. Bilgin, Linda Katharina Karlsson, Josip Batinić, Anna Nordlander, Martin Schönlein, Martin Hoenigl, Zdeněk Ráčil, Miloš Mladenović, Michaela Hanakova, Giovanni Paolo Maria Zambrotta, Nick De Jonge, Tatjana Adžić-Vukičević, Raquel Nunes-Rodrigues, Lucia Prezioso, Milan Navrátil, Monia Marchetti, Annarosa Cuccaro, Maria Calbacho, Antonio Giordano, Oliver A. Cornely, José-Ángel Hernández-Rivas, Livio Pagano
Publikováno v:
FRONTIERS IN ONCOLOGY
Scientia
Infante, M S, Salmanton-García, J, Fernández-Cruz, A, Marchesi, F, Jaksic, O, Weinbergerová, B, Besson, C, Duarte, R F, Itri, F, Valković, T, Szotkovski, T, Busca, A, Guidetti, A, Glenthøj, A, Collins, G P, Bonuomo, V, Sili, U, Seval, G C, Machado, M, Cordoba, R, Blennow, O, Abu-Zeinah, G, Lamure, S, Kulasekararaj, A, Falces-Romero, I, Cattaneo, C, van Doesum, J, Piukovics, K, Omrani, A S, Magliano, G, Ledoux, M-P, de Ramon, C, Cabirta, A, Verga, L, López-García, A, da Silva, M G, Stojanoski, Z, Meers, S, Lahmer, T, Martín-Pérez, S, Dávila-Vals, J, van Praet, J, Samarkos, M, Bilgin, Y M, Karlsson, L K, Batinić, J, Nordlander, A, Schönlein, M, Hoenigl, M, Ráčil, Z, Mladenović, M, Hanakova, M, Zambrotta, G P M, de Jonge, N, Adžić-Vukičević, T, Nunes-Rodrigues, R, Prezioso, L, Navrátil, M, Marchetti, M, Cuccaro, A, Calbacho, M, Giordano, A, Cornely, O A, Hernández-Rivas, J-Á & Pagano, L 2022, ' B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : A European Hematology Association Survey (EPICOVIDEHA) ', Frontiers in Oncology, vol. 12, 992137 . https://doi.org/10.3389/fonc.2022.992137
Frontiers in Oncology, 12:992137. Frontiers Media SA
Frontiers in Oncology, 12:992137. Frontiers Media S.A.
Infante, M S, Salmanton-García, J, Fernández-Cruz, A, Marchesi, F, Jaksic, O, Weinbergerová, B, Besson, C, Duarte, R F, Itri, F, Valković, T, Szotkovski, T, Busca, A, Guidetti, A, Glenthøj, A, Collins, G P, Bonuomo, V, Sili, U, Seval, G C, Machado, M, Cordoba, R, Blennow, O, Abu-Zeinah, G, Lamure, S, Kulasekararaj, A, Falces-Romero, I, Cattaneo, C, Van Doesum, J, Piukovics, K, Omrani, A S, Magliano, G, Ledoux, M-P, de Ramon, C, Cabirta, A, Verga, L, López-García, A, Da Silva, M G, Stojanoski, Z, Meers, S, Lahmer, T, Martín-Pérez, S, Dávila-Vals, J, Van Praet, J, Samarkos, M, Bilgin, Y M, Karlsson, L K, Batinić, J, Nordlander, A, Schönlein, M, Hoenigl, M, Ráčil, Z, Mladenović, M, Hanakova, M, Zambrotta, G P M, De Jonge, N, Adžić-Vukičević, T, Nunes-Rodrigues, R, Prezioso, L, Navrátil, M, Marchetti, M, Cuccaro, A, Calbacho, M, Giordano, A, Cornely, O A, Hernández-Rivas, J Á & Pagano, L 2022, ' B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : A European Hematology Association Survey (EPICOVIDEHA) ', Frontiers in Oncology, vol. 12, 992137 . https://doi.org/10.3389/fonc.2022.992137
Frontiers in Oncology
Volume 12
Scientia
Infante, M S, Salmanton-García, J, Fernández-Cruz, A, Marchesi, F, Jaksic, O, Weinbergerová, B, Besson, C, Duarte, R F, Itri, F, Valković, T, Szotkovski, T, Busca, A, Guidetti, A, Glenthøj, A, Collins, G P, Bonuomo, V, Sili, U, Seval, G C, Machado, M, Cordoba, R, Blennow, O, Abu-Zeinah, G, Lamure, S, Kulasekararaj, A, Falces-Romero, I, Cattaneo, C, van Doesum, J, Piukovics, K, Omrani, A S, Magliano, G, Ledoux, M-P, de Ramon, C, Cabirta, A, Verga, L, López-García, A, da Silva, M G, Stojanoski, Z, Meers, S, Lahmer, T, Martín-Pérez, S, Dávila-Vals, J, van Praet, J, Samarkos, M, Bilgin, Y M, Karlsson, L K, Batinić, J, Nordlander, A, Schönlein, M, Hoenigl, M, Ráčil, Z, Mladenović, M, Hanakova, M, Zambrotta, G P M, de Jonge, N, Adžić-Vukičević, T, Nunes-Rodrigues, R, Prezioso, L, Navrátil, M, Marchetti, M, Cuccaro, A, Calbacho, M, Giordano, A, Cornely, O A, Hernández-Rivas, J-Á & Pagano, L 2022, ' B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : A European Hematology Association Survey (EPICOVIDEHA) ', Frontiers in Oncology, vol. 12, 992137 . https://doi.org/10.3389/fonc.2022.992137
Frontiers in Oncology, 12:992137. Frontiers Media SA
Frontiers in Oncology, 12:992137. Frontiers Media S.A.
Infante, M S, Salmanton-García, J, Fernández-Cruz, A, Marchesi, F, Jaksic, O, Weinbergerová, B, Besson, C, Duarte, R F, Itri, F, Valković, T, Szotkovski, T, Busca, A, Guidetti, A, Glenthøj, A, Collins, G P, Bonuomo, V, Sili, U, Seval, G C, Machado, M, Cordoba, R, Blennow, O, Abu-Zeinah, G, Lamure, S, Kulasekararaj, A, Falces-Romero, I, Cattaneo, C, Van Doesum, J, Piukovics, K, Omrani, A S, Magliano, G, Ledoux, M-P, de Ramon, C, Cabirta, A, Verga, L, López-García, A, Da Silva, M G, Stojanoski, Z, Meers, S, Lahmer, T, Martín-Pérez, S, Dávila-Vals, J, Van Praet, J, Samarkos, M, Bilgin, Y M, Karlsson, L K, Batinić, J, Nordlander, A, Schönlein, M, Hoenigl, M, Ráčil, Z, Mladenović, M, Hanakova, M, Zambrotta, G P M, De Jonge, N, Adžić-Vukičević, T, Nunes-Rodrigues, R, Prezioso, L, Navrátil, M, Marchetti, M, Cuccaro, A, Calbacho, M, Giordano, A, Cornely, O A, Hernández-Rivas, J Á & Pagano, L 2022, ' B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection : A European Hematology Association Survey (EPICOVIDEHA) ', Frontiers in Oncology, vol. 12, 992137 . https://doi.org/10.3389/fonc.2022.992137
Frontiers in Oncology
Volume 12
Patients with lymphoproliferative diseases (LPD) are vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we describe and analyze the outcome of 366 adult patients with chronic lymphocytic leukemia (CLL) or non-
Autor:
Dorsch, Judith
Objectives: The aim of this study was to determine and compare the prevalence of malnutri-tion in pancreatic and colorectal cancer patients attending the outpatient clinic presenting for diagnosis, therapy or follow-up. Additionally, the study invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4112::0a6368b342b032049f52b905e68fc43b
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1585/datastream/PDF
https://repozitorij.svkst.unist.hr/islandora/object/mefst:1585/datastream/PDF
Autor:
Schwenkenbecher, Finja Marie
Objectives: The purpose of this study is to confirm, whether detailed genetic testing of patients with advanced tumor stage provides the basis for new molecular targeted therapies and to determine, if detailed genetic testing extends treatment option
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3f9814f43fbde6a0e2900affa9694c7a
https://urn.nsk.hr/urn:nbn:hr:171:706220
https://urn.nsk.hr/urn:nbn:hr:171:706220